Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran Turaga

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The British Journal of Surgery|June 25, 2025
Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensusAditi Bhatt, Artem Stepanyan, Brendan J Moran, et al.
The British Journal of Surgery|June 25, 2025
Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundariesAditi Bhatt, Christina Fotopoulou, Brendan J Moran, et al.
The Lancet. Oncology|April 2, 2026
Principles of cytoreductive surgery for primary and metastatic peritoneal malignancies-the PSOGI-ESGO-ISSPP Lyon consensusAditi Bhatt, Artem Stepanyan, Ahmed Al-Niaimi, et al.
Annals of Surgical Oncology|May 24, 2014
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal CarcinomatosisJesus Esquivel, Andrew M Lowy, Maurie Markman, et al.
Cancer Discovery|November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic DiseaseDaniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.
JAMA Network Open|August 9, 2023
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With MesotheliomaOwen D Mitchell, Katie Gilliam, Daniela Del Gaudio, et al.
Journal of Surgical Oncology|August 5, 2014
The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgeryArancha Prada-Villaverde, Jesus Esquivel, Andrew M Lowy, et al.
JAMA Network Open|February 15, 2020
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical TrialDaniel V T Catenacci, Leah Chase, Samantha Lomnicki, et al.
Genome Biology|May 10, 2022
Refining colorectal cancer classification and clinical stratification through a single-cell atlasAteeq M Khaliq, Cihat Erdogan, Zeyneb Kurt, et al.
Genome Biology|July 13, 2022
Correction: Refining colorectal cancer classification and clinical stratification through a single-cell atlasAteeq M Khaliq, Cihat Erdogan, Zeyneb Kurt, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The British Journal of Surgery|June 25, 2025
Peritonectomy procedures for peritoneal surface malignancies: PSOGI-ESGO-ISSPP Lyon consensusAditi Bhatt, Artem Stepanyan, Brendan J Moran, et al.
The British Journal of Surgery|June 25, 2025
Peritonectomy to enhance adequate cytoreductive surgery in peritoneal surface malignancy: review of nomenclature and boundariesAditi Bhatt, Christina Fotopoulou, Brendan J Moran, et al.
The Lancet. Oncology|April 2, 2026
Principles of cytoreductive surgery for primary and metastatic peritoneal malignancies-the PSOGI-ESGO-ISSPP Lyon consensusAditi Bhatt, Artem Stepanyan, Ahmed Al-Niaimi, et al.
Annals of Surgical Oncology|May 24, 2014
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal CarcinomatosisJesus Esquivel, Andrew M Lowy, Maurie Markman, et al.
Cancer Discovery|November 25, 2020
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic DiseaseDaniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, et al.
JAMA Network Open|August 9, 2023
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With MesotheliomaOwen D Mitchell, Katie Gilliam, Daniela Del Gaudio, et al.
Journal of Surgical Oncology|August 5, 2014
The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgeryArancha Prada-Villaverde, Jesus Esquivel, Andrew M Lowy, et al.
JAMA Network Open|February 15, 2020
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical TrialDaniel V T Catenacci, Leah Chase, Samantha Lomnicki, et al.
Genome Biology|May 10, 2022
Refining colorectal cancer classification and clinical stratification through a single-cell atlasAteeq M Khaliq, Cihat Erdogan, Zeyneb Kurt, et al.
Genome Biology|July 13, 2022
Correction: Refining colorectal cancer classification and clinical stratification through a single-cell atlasAteeq M Khaliq, Cihat Erdogan, Zeyneb Kurt, et al.
Pageof 5